Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors

Journal of Investigative Dermatology

Volumn 130, Issue 12, 2010, Pages 2844-2848

  Scherer, Dominique ^a   Rachakonda, P Sivaramakrishna ^a   Angelini, Sabrina ^a,b   Mehnert, Franziska ^a   Sucker, Antje ^c   Egberts, Friederike ^d   Hauschild, Axel ^d   Hemminki, Kari ^a   Schadendorf, Dirk ^c   Kumar, Rajiv ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MELANOCORTIN 1 RECEPTOR;

CANCER GENETICS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERM LINE; HUMAN; HUMAN TISSUE; LETTER; MELANOMA; ONCOGENE N RAS; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 78149471000     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.242     Document Type: Letter

References (14)

1. Box NF, Duffy DL, Chen W et al. (2001) MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 69:765-73
2. Dhomen N, Marais R (2007) New insight into BRAF mutations in cancer. Curr Opin Genet Dev 17:31-9
3. Dumaz N, Hayward R, Martin J et al. (2006) In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res 66:9483-91
4. Fargnoli MC, Pike K, Pfeiffer RM et al. (2008) MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol 128:2485-90
5. Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C (2005) Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 18:393-410
6. Hacker E, Hayward NK, Dumenil T et al. (2009) The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population. J Invest Dermatol 130: 241-8
7. Jaeger J, Koczan D, Thiesen HJ et al. (2007) Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res 13:806-15
8. Landi MT, Bauer J, Pfeiffer RM et al. (2006) MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313:521-2
9. Michaloglou C, Vredeveld LC, Mooi WJ et al. (2008) BRAF (E600) in benign and malignant human tumours. Oncogene 27:877-95
10. Rees JL (2003) Genetics of hair and skin color. Annu Rev Genet 37:67-90
11. Scherer D, Nagore E, Bermejo JL et al. (2009) Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int J Cancer 125:1868-75
12. Sulem P, Gudbjartsson DF, Stacey SN et al. (2007) Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 39: 1443-52
13. Thomas NE, Kanetsky PA, Edmiston SN et al. (2010) Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study. J Invest Dermatol 130:1463-5
14. Warycha MA, Christos PJ, Mazumdar M et al. (2008) Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer 113:3341-8